Fingerprint
Dive into the research topics of 'A phase I pharmacodynamic trial of bortezomib in combination with doxorubicin in patients with advanced cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase I pharmacodynamic trial of bortezomib in combination with doxorubicin in patients with advanced cancer
Noelle K. LoConte, James P. Thomas, Dona Alberti, Jennifer Heideman, Kimberly Binger, Rebecca Marnocha, Kyle Utecht, Peter Geiger, Jens Eickhoff, George Wilding, Jill Kolesar
Research output: Contribution to journal › Article › peer-review
18
Scopus
citations